Robert J Porte
Erasmus Medical Center · University Medical Center Groningen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert J Porte as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:50 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07651748 · Secretin in Ex-situ Liver PerfusionErasmus Medical Center · enrolling by invitation · Liver Transplantation · principal investigator
- Ph3NCT02584283 · Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After TransplantationRobert J. Porte · completed · Liver Failure, End Stage Liver Disease, Biliary Tract Diseases · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:50 UTC. The ranking covers the 200 most relevant of 33 PubMed records, and a shared surname and initials can bring in a namesake. All 33 on PubMed
- Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.N Engl J Med · 2021540 citationsRCR 40.8
- 214 citationsRCR 11.4
- 202 citationsRCR 6.9
- Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.Transplantation · 2001186 citationsRCR 6.6
- Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.Liver Transpl · 2005164 citationsRCR 5.4
- A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation.J Hepatol · 2023162 citationsRCR 21.4
- Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial.Lancet Gastroenterol Hepatol · 2018150 citationsRCR 7.7
- Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers.Liver Transpl · 201884 citationsRCR 3.8
- Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.PLoS One · 201676 citationsRCR 3.4
- Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.BMC Surg · 201356 citationsRCR 2.3